HDVY — Health Discovery Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.04m
- $0.20m
- $0.00m
Annual cashflow statement for Health Discovery, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.07 | -0.874 | -0.795 | 1.56 | -0.759 |
| Amortisation | |||||
| Non-Cash Items | 1.31 | 0.079 | 0.087 | 0.513 | -0.724 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.029 | 0.218 | 0.17 | -0.024 | 0.104 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.466 | -0.314 | -0.276 | 2.2 | -1.38 |
| Other Investing Cash Flow Items | 0 | 0.141 | 0 | 0 | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0 | 0.141 | 0 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.09 | 0.175 | 0.232 | 0.093 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.376 | 0.002 | -0.043 | 2.3 | -1.38 |